• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, September 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

Complete clearance of hepatitis B is rare — especially in women…

Bioengineer.org by Bioengineer.org
January 26, 2018
in Headlines, Health, Science News
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

hepatitis-b

Researchers at several different US sites have found that less than one-third of 1% of patients infected with hepatitis B virus (HBV) get rid of the virus per year, and overall, only 1.2% of patients finally get rid of it.

Men were twice as likely as women to clear the virus completely. People of Asian descent were less likely than other racial or ethnic groups to clear the virus. People over the age of 45 were almost twice as likely to get rid of the virus as younger patients.

HBV infection is extremely common, affecting approximately 250 million people worldwide, and it can lead to liver cirrhosis and liver cancer.

“We felt it was important to highlight just how rarely this highly desirable outcome called seroclearance occurs in what we believe to be the largest North American study of its kind,” said Dr. Long Nguyen, lead author of the Alimentary Pharmacology & Therapeutics analysis. ”

“This is further proof that our current standard therapies — for which viral suppression rather than elimination are the goal — may not suffice and that more research should be dedicated to therapeutics that help achieve viral cure,” added senior author Dr. Mindie Nguyen

###

Media Contact

Penny Smith
[email protected]

http://www.wiley.com/wiley-blackwell

Photo Credit: Punch Newspaper,Dated March 5,2012

Share14Tweet9Share2ShareShareShare2

Related Posts

Study Finds Children Benefit More from Biofeedback Speech Therapy Compared to Traditional Approaches

Study Finds Children Benefit More from Biofeedback Speech Therapy Compared to Traditional Approaches

September 8, 2025
Targeted Degradation of Keap1: A Novel PROTAC Approach for Treating Allergic Rhinitis

Targeted Degradation of Keap1: A Novel PROTAC Approach for Treating Allergic Rhinitis

September 8, 2025

Moffitt Creates First Genetically Engineered Cancer Model in Naked Mole Rats

September 8, 2025

Highly Efficient Discovery of Potent Anti-Notum Agents from Herbal Medicines to Combat Glucocorticoid-Induced Osteoporosis

September 8, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    151 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Study Finds Children Benefit More from Biofeedback Speech Therapy Compared to Traditional Approaches

Targeted Degradation of Keap1: A Novel PROTAC Approach for Treating Allergic Rhinitis

Moffitt Creates First Genetically Engineered Cancer Model in Naked Mole Rats

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.